The FDA has just approved Moderna’s new RSV mRNA vaccine. The new vaccine by Moderna is for adults over the age of 60. Moderna CEO Stephane Bancel said in a press release, “The FDA approval of our second product, mRESVIA, builds on the strength and versatility of our mRNA platform.” “mRESVIA protects older adults from … Continue reading FDA Approves New mRNA Vaccine